Publications by authors named "M A Faliva"
Article Synopsis
- This study looks at different ways to treat obesity, comparing short stays in the hospital to outpatient programs where people don’t stay in the hospital.
- Researchers found that people who stayed in the hospital for a short time lost more weight and had a better BMI than those who were treated outside the hospital for a longer time.
- The conclusion is that starting with a short hospital program can be more effective for losing weight than just going to outpatient treatment.
The aim of this study is to assess the bone mineral density (BMD) and -score reference values in a population from 18 to 95 years old in Lombardy region, Italy. This study also investigates the association between BMD values and body mass index (BMI) divided by gender and age. The evaluation of BMD was analyzed by -score and BMD in each site, femur, and column.
View Article and Find Full Text PDFIntroduction: The aim of the present study was to assess the dropout rate at 2, 6, and 12 months after an inpatient multidisciplinary residential program (MRP) for the treatment of obesity. Furthermore, this study assessed anthropometric and biochemical predictors associated with the dropout.
Methods: Adult and elderly patients (age 59 ± 14 years) with obesity had undergone an MRP, were followed up from 2 to 12 months.
Multidisciplinary residential program for the treatment of obesity: how body composition assessed by DXA and blood chemistry parameters change during hospitalization and which variations in body composition occur from discharge up to 1-year follow-up.
Eat Weight Disord
October 2022
Purpose: Obesity is a chronic disease characterized by a complex variable clinical presentation with comorbidities. A multidisciplinary residential program (MRP) represents one of the best options for treating obesity. The purpose of this study was to evaluate the effectiveness of 8-week MRP on weight loss, body composition assessed by DXA, and metabolic blood parameters between entry (T0) and discharge (T1).
View Article and Find Full Text PDFQuercetin, for its crucial properties, fulfills the need for a multifactor action that is useful for the potential counterbalance of a COVID-19 infection. Given this background, the aim of the study was to evaluate the potential effect of 3 months' supplementation with Quercetin Phytosome (250 mg twice a day) as prevention against symptomatic COVID-19. In total, 120 subjects were enrolled (males, 63; females, 57; age 49 ± 12), with 60 in the supplementation group and 60 in the placebo group.
View Article and Find Full Text PDF